Biocon leads India push into weight loss drugs as patents lapse

The Bengaluru-based firm has scored an early win among its peers with the UK approval for the first generic version of liraglutide injectible, which is losing patent protection in November.

from Moneycontrol Business News https://ift.tt/bISDePx